Efficacy and Safety of Rilpivirine (TMC278) Versus Efavirenz at 48 Weeks in Treatment-Naive HIV-1­Infected Patients: Pooled Results From the Phase 3 Double-Blind Randomized ECHO and THRIVE Trials

Cohen, Calvin J.; Molina, Jean-Michel; Cahn, Pedro; Clotet, Bonaventura; Fourie, Jan; Grinsztejn, Beatriz; Wu, Hao; Johnson, Margaret A.; Saag, Michael; Supparatpinyo, Khuanchai; Crauwels, Herta; Lefebvre, Eric; Rimsky, Laurence T.; Vanveggel, Simon; Williams, Peter; Boven, Katia; ECHO Study Group; THRIVE Study Group.
Artículo en Inglés | ARCA | ID: arc-29993

Documentos relacionados

  1. [Clotiapine in the treatment of acutely agitated patients: hardly any evidence].
  2. [Venous thromboembolic complications in oncological patients: present-day possibilities of effective and safe anticoagulant therapy].
  3. [Urinary incontinence in geriatric patients: pharmacological Therapy].
  4. [The impact of listening to music on orthopedic patients: a randomized controlled trial].
  5. [Droperidol for the treatment of acutely agitated patients: still an option].
  6. [Cancer Patients: Relevant Aspects for Anesthesiology].
  7. [Safety in Intensive Home Care for Ventilated Patients: Professional Players' Perspective].
  8. [An Important Problem in AdV-36 Seropositive Obesity Patients: Leptin Resistance].
  9. [Cicatricial tracheal stenosis in elderly and senile patients: immediate and long-term results of treatment].
  10. [Development of a Psychosocial Online Self-Help Program for Cancer Patients: A Patient-Oriented Approach].